Dennis Slamon - Net Worth and Insider Trading
Dennis Slamon Net Worth
The estimated net worth of Dennis Slamon is at least $1 Million dollars as of 2025-04-28. Dennis Slamon is the Director of Biomarin Pharmaceutical Inc and owns about 21,639 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $1 Million. Details can be seen in Dennis Slamon's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dennis Slamon has not made any transactions after 2022-02-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dennis Slamon
Dennis Slamon Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dennis Slamon owns 1 companies in total, including Biomarin Pharmaceutical Inc (BMRN) .
Click here to see the complete history of Dennis Slamon’s form 4 insider trades.
Insider Ownership Summary of Dennis Slamon
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 2022-02-28 | director |
Dennis Slamon Latest Holdings Summary
Dennis Slamon currently owns a total of 1 stock. Dennis Slamon owns 21,639 shares of Biomarin Pharmaceutical Inc (BMRN) as of February 28, 2022, with a value of $1 Million.
Latest Holdings of Dennis Slamon
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 2022-02-28 | 21,639 | 63.30 | 1,369,749 |
Holding Weightings of Dennis Slamon
Dennis Slamon Form 4 Trading Tracker
According to the SEC Form 4 filings, Dennis Slamon has made a total of 1 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 6,396 shares on February 28, 2022, which brought Dennis Slamon around $500,999.
Insider Trading History of Dennis Slamon
- 1
Dennis Slamon Trading Performance
Dennis Slamon Ownership Network
Ownership Network List of Dennis Slamon
Ownership Network Relation of Dennis Slamon
Dennis Slamon Owned Company Details
What does Biomarin Pharmaceutical Inc do?
Who are the key executives at Biomarin Pharmaceutical Inc?
Dennis Slamon is the director of Biomarin Pharmaceutical Inc. Other key executives at Biomarin Pharmaceutical Inc include GVP & Chief Accounting Officer Erin Burkhart , EVP & Chief Technical Officer Charles Greg Guyer , and EVP & Chief Financial Officer Brian Mueller .
Biomarin Pharmaceutical Inc (BMRN) Insider Trades Summary
Over the past 18 months, Dennis Slamon made no insider transaction in Biomarin Pharmaceutical Inc (BMRN). Other recent insider transactions involving Biomarin Pharmaceutical Inc (BMRN) include a net sale of 143,000 shares made by Jean Jacques Bienaime , a net sale of 81,066 shares made by George Eric Davis , and a net sale of 5,639 shares made by Erin Burkhart .
In summary, during the past 3 months, insiders sold 9,673 shares of Biomarin Pharmaceutical Inc (BMRN) in total and bought 0 shares, with a net sale of 9,673 shares. During the past 18 months, 291,358 shares of Biomarin Pharmaceutical Inc (BMRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 291,358 shares.
Biomarin Pharmaceutical Inc (BMRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biomarin Pharmaceutical Inc Insider Transactions
Dennis Slamon Mailing Address
Above is the net worth, insider trading, and ownership report for Dennis Slamon. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Dennis Slamon's mailing address is: San Rafael Ca 94901.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
